Lexicon Pharmaceuticals, Inc.: Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) ("Lexicon") today announced the closing of its previously announced underwritten public offering of ...